164 related articles for article (PubMed ID: 22024288)
1. Serum visfatin and vaspin levels in normoglycemic first-degree relatives of Iranian patients with type 2 diabetes mellitus.
Akbarzadeh S; Nabipour I; Jafari SM; Movahed A; Motamed N; Assadi M; Hajian N
Diabetes Res Clin Pract; 2012 Jan; 95(1):132-8. PubMed ID: 22024288
[TBL] [Abstract][Full Text] [Related]
2. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].
Zhang XJ; Wang Z; Li HH; Yu L; Gao S
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671
[TBL] [Abstract][Full Text] [Related]
3. The normoglycemic first-degree relatives of patients with type 2 diabetes mellitus have low circulating omentin-1 and adiponectin levels.
Akbarzadeh S; Nabipour I; Assadi M; Movahed A; Jafari SM; Motamed N; Nazem H; Haraghy M; Pourbehi A; Bargahi A; Hajian N
Cytokine; 2012 May; 58(2):295-9. PubMed ID: 22398372
[TBL] [Abstract][Full Text] [Related]
4. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
Alghasham AA; Barakat YA
Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
[TBL] [Abstract][Full Text] [Related]
5. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism.
Martos-Moreno GÁ; Kratzsch J; Körner A; Barrios V; Hawkins F; Kiess W; Argente J
Int J Obes (Lond); 2011 Oct; 35(10):1355-62. PubMed ID: 21266955
[TBL] [Abstract][Full Text] [Related]
6. Apelin, vaspin, visfatin and adiponectin in large for gestational age infants with insulin resistance.
Cekmez F; Canpolat FE; Pirgon O; Çetinkaya M; Aydinoz S; Suleymanoglu S; Ipcioglu OM; Sarici SU
Cytokine; 2011 Nov; 56(2):387-91. PubMed ID: 21742512
[TBL] [Abstract][Full Text] [Related]
7. Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome.
Ozkaya M; Cakal E; Ustun Y; Engin-Ustun Y
Fertil Steril; 2010 Feb; 93(3):880-4. PubMed ID: 19111298
[TBL] [Abstract][Full Text] [Related]
8. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N
Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
[TBL] [Abstract][Full Text] [Related]
9. Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.
Chu CH; Lee JK; Wang MC; Lu CC; Sun CC; Chuang MJ; Lam HC
Metabolism; 2008 Oct; 57(10):1380-3. PubMed ID: 18803942
[TBL] [Abstract][Full Text] [Related]
10. Circulating visfatin level is correlated with inflammation, but not with insulin resistance.
Oki K; Yamane K; Kamei N; Nojima H; Kohno N
Clin Endocrinol (Oxf); 2007 Nov; 67(5):796-800. PubMed ID: 17634078
[TBL] [Abstract][Full Text] [Related]
11. The comparison of serum vaspin and visfatin concentrations in obese and normal weight women.
Saboori S; Hosseinzadeh-Attar MJ; Yousefi Rad E; Hosseini M; Mirzaei K; Ahmadivand Z
Diabetes Metab Syndr; 2015; 9(4):320-3. PubMed ID: 25470626
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of novel adipocytokines in patients with colorectal cancer.
Fazeli MS; Dashti H; Akbarzadeh S; Assadi M; Aminian A; Keramati MR; Nabipour I
Cytokine; 2013 Apr; 62(1):81-5. PubMed ID: 23474107
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
[TBL] [Abstract][Full Text] [Related]
14. Impact of atorvastatin on serum vaspin levels in hypercholesterolemic patients with moderate cardiovascular risk.
Kadoglou NP; Vrabas IS; Kapelouzou A; Lampropoulos S; Sailer N; Kostakis A; Liapis CD
Regul Pept; 2011 Oct; 170(1-3):57-61. PubMed ID: 21640762
[TBL] [Abstract][Full Text] [Related]
15. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.
Nüsken KD; Petrasch M; Rauh M; Stöhr W; Nüsken E; Schneider H; Dötsch J
Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
[TBL] [Abstract][Full Text] [Related]
17. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.
Dogru T; Sonmez A; Tasci I; Bozoglu E; Yilmaz MI; Genc H; Erdem G; Gok M; Bingol N; Kilic S; Ozgurtas T; Bingol S
Diabetes Res Clin Pract; 2007 Apr; 76(1):24-9. PubMed ID: 16956691
[TBL] [Abstract][Full Text] [Related]
18. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.
Agueda M; Lasa A; Simon E; Ares R; Larrarte E; Labayen I
Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014
[TBL] [Abstract][Full Text] [Related]
19. Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters.
Caixàs A; Tirado R; Vendrell J; Gallart L; Megía A; Simón I; Llauradó G; González-Clemente JM; Giménez-Palop O
Clin Endocrinol (Oxf); 2009 Nov; 71(5):733-8. PubMed ID: 19222486
[TBL] [Abstract][Full Text] [Related]
20. Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC).
Pazgan-Simon M; Kukla M; Zuwała-Jagiełło J; Derra A; Bator M; Menżyk T; Lekstan A; Grzebyk E; Simon K
PLoS One; 2020; 15(1):e0227459. PubMed ID: 31935230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]